Arkolith/Insider Trading/NVCT/Form 4

Mosseri Marlio Charles

10% OwnerNuvectis Pharma, Inc. (NVCT) · full profile →Form 4 · filed Oct 29, 2025
Net Buying
Open-Market Buys
$957K
Open-Market Sells
$0
Net Open-Market Flow
$957K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 27, 2025Buy(P)73K$6.28$457K3.1M
Oct 24, 2025Buy(P)35K$6.15$215K3.1M
Oct 23, 2025Buy(P)47K$6.06$284K3.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-103522) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML